SynBioBeta, the leading community of entrepreneurs, investors, innovators, and biological engineers, today announced details for its flagship SynBioBeta 2024 conference. The premier annual event for the synthetic biology industry will be held May 6-9, 2024, in San Jose, gathering an estimated 2,000 attendees from around the world.
“Synthetic biology is rapidly transforming nearly every sector of our economy and society in profound ways,” said John Cumbers, founder of SynBioBeta. “Our annual conference brings together the world’s preeminent minds and companies driving innovation in this space to tackle humanity’s greatest challenges in health, sustainability, materials, and our fundamental understanding of life itself.”
SynBioBeta 2024 will feature over 180 content sessions across 18 tracks focused on the most critical frontiers in synthetic biology, including engineered human therapies, longevity, psychedelics, AI and digital biology, climate solutions, food and agriculture, chemicals and materials, biosecurity and more. A renowned line-up of over 200 speakers will take the stage, headlined by keynotes from Stephen Wolfram of Wolfram Research, Stephen Quake of the Chan Zuckerberg Initiative, investor Vinod Khosla of Khosla Ventures, genomics pioneer Craig Venter, mushroom expert Paul Stamets, biotech entrepreneur Martine Rothblatt, and Valerie Sarisky-Reed from the US Government’s Department of Energy.
“Taking the SynBioBeta stage is an unmatched opportunity to share our work with the people who truly comprehend its enormity,” said Jodi Barrientos, Chief Executive Officer at Ribbon Biolabs.” The audience is highly engaged, fostering stimulating discussions that have the potential to influence various fields such as medicine, materials science, and climate solutions. It is the ultimate gathering for those at the forefront of the synthetic biology revolution.”
The global synthetic biology market was valued at $6.3 billion in 2021 and is projected to grow at a staggering CAGR of around 25% to reach $38.7 billion by 2030 (Markets&Markets).
Key drivers include increasing demand for synthetic biology products in healthcare, industrial applications, food and agriculture, and rising investments.
In addition to the extensive conference programming, SynBioBeta 2024 will host over 200 exhibitors and sponsors showcasing the latest synthetic biology tools, technologies and applications. Exhibitors range from industry leaders like Ginkgo Bioworks and DNA Script to cutting-edge startups such as Asimov, Molecular Assemblies, and Ansa Biotechnologies.
“SynBioBeta is a mind-expanding experience that renews your sense of awe about the transformative potential of synthetic biology,” said Richard Kitney, Professor of Biomedical Systems Engineering and Co-Director of the UK’s National Industrial Translation Centre for Synthetic Biology at Imperial College London. “The cross-pollination of ideas, the windows into cutting-edge research, the ability to connect with the pioneers reimagining what’s possible with biology – it all conveys a future vision that is incredibly inspiring. You leave reinvigorated about this field’s power to solve humanity’s greatest challenges.”
A major highlight will be the SynBioBeta Global Synthetic Biology Awards ceremony recognizing standout achievement and impact across categories like Lifetime Achievement, Pioneer Award, Industry Leader Award, and Rising Star Award.
To register or apply to exhibit, speak, or sponsor at SynBioBeta 2024, please visit SynBioBeta 2024.
Media Relations:
Katie Orrell, Director of Marketing
About SynBioBeta
SynBioBeta is the premier innovation network for biological engineers, investors, innovators, and entrepreneurs who share a passion for using biology to build a better, more sustainable world. We provide our community members with personal and professional development support, as well as valuable opportunities for partnership, collaboration, networking, and education. We host The Global Synthetic Biology Conference each year, which highlights the innovative developments in synthetic biology that are transforming how we fuel, heal, and feed the world. Our Weekly Newsletter provides opportunities to highlight our partners research, thoughts, and discoveries while telling the story of the bioeconomy.